Lv1
80 积分 2021-07-11 加入
PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma
1天前
待确认
Lenzilumab in Addition to Azacitidine Improves Complete Response Rates in Chronic Myelomonocytic Leukemia
9个月前
已关闭
Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC
1年前
已完结
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
2年前
已完结
Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin
2年前
已关闭
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
2年前
已完结
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
2年前
已完结
Structure- and Similarity-Based Survey of Allosteric Kinase Inhibitors, Activators, and Closely Related Compounds
3年前
已完结
皖公网安备34019202002308
